We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Regulatory News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.35
Bid: 1.30
Ask: 1.40
Change: 0.125 (10.20%)
Spread: 0.10 (7.692%)
Open: 1.225
High: 1.35
Low: 1.20
Prev. Close: 1.225
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

4 Aug 2021 16:41

RNS Number : 6116H
Shield Therapeutics PLC
04 August 2021
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMDZGGRKDMGMZM

Date   Source Headline
11th Apr 20187:00 amRNSPreliminary Results for the Year Ended 31 Dec 17
6th Apr 20187:00 amRNSAppointment of Non-Executive Director
6th Apr 20187:00 amRNSResults of Pre-Submission Meeting with FDA
27th Mar 20187:00 amRNSBroadening of Feraccru indication
16th Mar 20187:00 amRNSUpdate on the AEGIS-CKD study
23rd Feb 20181:56 pmRNSReceives CHMP positive opinion on Feraccru®
22nd Feb 20187:00 amRNSBusiness and Trading Update
5th Feb 20187:00 amRNSTop-line results from Feraccru Phase III study
29th Jan 20187:00 amRNSNotice of Results
25th Jan 20187:00 amRNSGrant of share options
10th Oct 20177:00 amRNSCompletion of patient enrolment in Phase 3 study
5th Oct 20177:00 amRNSPDMR Acquisition of Shares
20th Sep 20177:00 amRNSInterim Report
14th Sep 20177:00 amRNSBoard Change
6th Sep 20177:00 amRNSUS Composition of Matter Patent Allowed
31st Aug 20177:00 amRNSShield to Present at Baird Healthcare Conference
15th Aug 20177:00 amRNSNotice of Results
11th Jul 20172:59 pmRNSGrant of Share Options
10th Jul 20174:16 pmRNSHolding(s) in Company
6th Jul 20177:00 amRNSFeraccru licence agreement for Switzerland
5th Jul 201712:38 pmRNSHolding(s) in Company
3rd Jul 201712:34 pmRNSWarrant Exercise and Expiry
28th Jun 201710:37 amRNSHolding(s) in Company
28th Jun 20178:00 amRNSAdmission of New Ordinary Shares
22nd Jun 20177:00 amRNSBiomarker data on ferric maltol in patients
15th Jun 20171:59 pmRNSResults of Fundraise
15th Jun 20177:00 amRNSProposed Fundraise
13th Jun 20172:40 pmRNSResult of AGM
26th May 20177:00 amRNSAppointment of Joint Broker
28th Apr 20177:00 amRNSAnnual Report, Accounts and AGM Notification
4th Apr 20177:00 amRNSAppointment of Chief Financial Officer
4th Apr 20177:00 amRNSPreliminary Results for the Year Ended 31 Dec 2016
13th Mar 20177:00 amRNSNotice of Results
13th Mar 20177:00 amRNSIP Portfolio Update
30th Jan 201710:50 amRNSDirectorate and Secretarial Update
6th Jan 20177:00 amRNSBusiness Update
7th Nov 20167:00 amRNSBoard Change
20th Sep 20167:00 amRNSInterim Results for six months ended 30 June 2016
13th Sep 20169:25 amRNSGrant of Share Awards
7th Sep 20167:37 amRNSComposition of Matter Patent Granted on Feraccru®
7th Sep 20167:00 amRNSComposition of Matter Patent Granted on Feraccru®
15th Aug 201612:22 pmRNSNotice of Results
4th Aug 201611:05 amRNSResult of AGM
1st Aug 201612:00 pmRNSPresenting at Canaccord Genuity Conference, Boston
30th Jun 20165:06 pmRNS2015 Annual Report and Accounts and Notice of AGM
14th Jun 20167:00 amRNSMaiden Preliminary Results for FY15
23rd Mar 20167:00 amRNSNotice of results and change of accounting date
11th Mar 20167:00 amRNSGrant of Share Awards
26th Feb 20168:34 amRNSFirst Day of Dealings on AIM
26th Feb 20167:00 amRNSFeraccru® receives EU marketing authorisation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.